Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)
NCT06716931 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24
Last updated 2026-04-15
Summary
An exercise regimen (PRIME: Proximal Resistance In-House Movement Exercise) has been designed for patients with myotonic dystrophy type 2 (DM2). The hypothesis is that this patient-friendly physical therapist (PT)-guided exercise program associates with improved functional capacity and muscle composition in DM2 in this two-period two-sequence cross-over study. Thus, participant will be randomized to one of the three possible groups. Participants in GROUP A will perform exercise routine virtually under the direct supervision of a physical therapist once a week and another session on their own for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP B will perform exercise routine virtually under the direct supervision of a physical therapist twice a week for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP C will perform exercise routine on their own during the first 3 months, then they will perform exercise routine virtually under the direct supervision of a physical therapist. Each group will include around 8 participants. Duration of the study is 6 months. In addition to exercise sessions, participants will have evaluation of their strength, motor function and muscle composition at three time points: initiation, 3 months and completion of the study at 6 months. Muscle composition will be assessed by electrical impedance myography which is a portable, non-invasive, painless and non-radiation tool that applies a weak high multifrequency electrical current to the examined muscle and allows to obtain information about its composition.
Conditions
- Myotonic Dystrophy 2
Interventions
- OTHER
-
Exercise
A patient-friendly exercise routine has been designed for patients with myotonic dystrophy type 2. Benefits of this exercise regimen in different settings (at home versus clinic, self-directed versus physical therapist-directed) will be investigated. In person exercise supervised by physical therapist and then self-directed exercise in Group A
- OTHER
-
Exercise
Exercise virtually supervised by physical therapist and then self-directed for group B
- OTHER
-
Exercise
Self-directed and virtually supervised exercise by physical therapist for Group C
Sponsors & Collaborators
-
Massachusetts General Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-04
- Primary Completion
- 2027-12-01
- Completion
- 2028-03-01
Countries
- United States
Study Locations
More Related Trials
-
Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy
NCT00004769 ·Status: COMPLETED
-
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
NCT06667453 ·Status: RECRUITING ·Phase: PHASE2
-
Aerobic Training in Patients With Congenital Myopathies
NCT02020187 ·Status: COMPLETED ·Phase: NA
-
This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy
NCT01098708 ·Status: COMPLETED
-
Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1
NCT06204809 ·Status: COMPLETED ·Phase: PHASE1
-
Strength Training in Duchenne Muscular Dystrophy
NCT02421523 ·Status: COMPLETED ·Phase: NA
-
Venous Thromboembolism in DM1
NCT03141749 ·Status: COMPLETED
-
Oxidative Capacity and Exercise Tolerance in Ambulatory SMA
NCT02895789 ·Status: COMPLETED
-
Arrhythmias in Myotonic Muscular Dystrophy
NCT00622453 ·Status: COMPLETED
-
Assessment of Energy Metabolism in Metabolic Myopathies
NCT07268287 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders
NCT00839033 ·Status: TERMINATED ·Phase: PHASE3
-
Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)
NCT03867435 ·Status: TERMINATED
-
Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)
NCT00468832 ·Status: UNKNOWN
-
Study of Morphology and Functional Magnetic Resonance Imaging (MRI) Muscle Patients With Muscular Dystrophy Type FSHD Benefiting a Physical Training Introduced.
NCT01990976 ·Status: COMPLETED
-
Whole Body Vibration Therapy in Boys With Duchenne Muscular Dystrophy
NCT01954940 ·Status: COMPLETED ·Phase: NA
-
The Effect of Aerobic Exercise, on Fitness and Functional Muscle Strength, in Patients With Muscular Dystrophy
NCT01895283 ·Status: COMPLETED ·Phase: NA
-
Expanded Access Study of UC-MSC in DMD Patients
NCT06579352 ·Status: AVAILABLE
-
Breathlessness Assessment in Adult Patients With Myotonic Dystrophy Type 1
NCT04835298 ·Status: COMPLETED
-
Observational Study of Digital Biomarkers of Myotonia and Gait in Adults and Children With Myotonic Dystrophy
NCT06089018 ·Status: ACTIVE_NOT_RECRUITING
-
Hydrotherapy in Duchenne Muscular Dystrophy (DMD)
NCT06445985 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Tolerance of Early Launching of Nocturnal Non Invasive
NCT01225614 ·Status: UNKNOWN ·Phase: PHASE3
-
Twice Weekly Steroids and Exercise as Therapy for DMD
NCT04322357 ·Status: COMPLETED ·Phase: PHASE2
-
A Low Interventional Study to Monitor Activity Using Wearable Sensors in Duchenne Muscular Dystrophy
NCT04254172 ·Status: TERMINATED
-
Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy
NCT05016908 ·Status: RECRUITING
-
Diet and Exercise in Pompe Disease
NCT02363153 ·Status: COMPLETED ·Phase: NA